Coronavirus: US authorises use of anti-viral drug Remdesivir to treat coronavirus patients






Antiviral drug remdesivir has been approved by US regulators to treat hospitalized Covid-19 patients.

After studies showed remdesivir a drug previously used to treat ebola patients, shortened recovery time by 31 percent, or around four days on average, for hospitalized Covid-19 patients, Food and Drug Administration (FDA) cleared its use.

Patients given the remdesivir drug were able to leave the hospital in 11 days on average, compared to 15 days for the placebo group. The drug may also help avert deaths, but that effect is not yet large enough for scientists to know for sure.

Now, the drug can be administered to patients with severe conditions, such as those experiencing breathing problems requiring supplemental oxygen or ventilators.

But during public health emergencies, the agency can waive those standards and require only that an experimental treatment’s potential benefits outweigh its risks.



Coronavirus: US authorises use of anti-viral drug Remdesivir to treat coronavirus patients Coronavirus: US authorises use of anti-viral drug Remdesivir to treat coronavirus patients Reviewed by Kola Oyewole on May 02, 2020 Rating: 5

No comments:

Powered by Blogger.